Literature DB >> 2505333

Lipid mediator production by post-implantation rat embryos in vitro.

F T Geissler1, F B Kuzan, E M Faustman, W R Henderson.   

Abstract

The production of inflammatory lipid mediators by post-implantation rodent embryos was examined in this study. Explanted day 10 rat embryos, either intact or after homogenization, were cultured for 3 hr in vitro and the resulting culture medium and embryonic tissue were assessed for eicosanoids and platelet-activating factor (PAF). The rank order of cyclooxygenase arachidonate products produced by intact embryos was as follows: 6-keto-PGF1 alpha much greater than congruent to PGF2 alpha congruent to TXB2. No lipoxygenase products of arachidonic acid metabolism were detected by either high performance liquid chromatography or radioimmunoassay. PAF production was detectable in embryonic cultures. Homogenization of rat embryos prior to in vitro culture enhanced eicosanoid and PAF production from 2.1-6.9 fold over intact embryos. These findings demonstrate the extent of lipid metabolism by early post-implantation rat embryos and support the concept that potent lipid mediators of inflammation generated by the conceptus may play a role in both the initiation and maintenance of pregnancy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505333     DOI: 10.1016/0090-6980(89)90078-6

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  4 in total

Review 1.  PAF. A review of its effects, antagonists and possible future clinical implications (Part II).

Authors:  M Koltai; D Hosford; P Guinot; A Esanu; P Braquet
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

2.  Group B streptococci (GBS) injure lung endothelium in vitro: GBS invasion and GBS-induced eicosanoid production is greater with microvascular than with pulmonary artery cells.

Authors:  R L Gibson; C Soderland; W R Henderson; E Y Chi; C E Rubens
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

3.  Human platelet-mediated cytotoxicity against Toxoplasma gondii: role of thromboxane.

Authors:  E C Yong; E Y Chi; T R Fritsche; W R Henderson
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

4.  Toxoplasma gondii alters eicosanoid release by human mononuclear phagocytes: role of leukotrienes in interferon gamma-induced antitoxoplasma activity.

Authors:  E C Yong; E Y Chi; W R Henderson
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.